Stock comparison
IDEXX Laboratories
Insulet
Scored across Buffett, Graham, Lynch and Greenblatt - plus a side-by-side metric table covering valuation, quality, growth and balance sheet.
IDXX
IDEXX Laboratories
Market cap
$42.11B
Sector
Healthcare
PODD
Insulet
Market cap
$10.31B
Sector
Healthcare
Overall winner
IDEXX Laboratories IDXX
Wins on the combined sum of fit scores across all four strategies. Per-strategy breakdown below.
Fit scores by strategy
| Strategy | IDXX | PODD | Winner |
|---|---|---|---|
| Warren Buffett | 67B | 52C | IDXX |
| Benjamin Graham | 72B | 77B | PODD |
| Philip Fisher |
Side-by-side metrics
| Metric | IDXX | PODD |
|---|---|---|
| Market cap | $42.11B | $10.31B |
| P/E (TTM) | 39.0x | 34.4x |
| EV/EBIT | 31.6x | 22.7x |
| ROIC (TTM) | 40.66% | 16.39% |
| Gross margin | 62.05% | 71.01% |
| Net margin | 24.63% | 10.44% |
| Revenue CAGR 5y | 7.56% |
Where each one wins
The metrics with the biggest gap between the two - sorted so the most decisive edges read first.
IDXX leads on
- Market cap$42.11Bvs $10.31B+76%
- ROIC (TTM)40.66%vs 16.39%+60%
- Net margin24.63%vs 10.44%+58%
PODD leads on
More like PODD
Related on invest-like
Educational tool. Fit scores are deterministic projections from public financials onto each investor's published criteria - not personal recommendations or advice.